Liu R, Gao L, Zhang X, Ge P, Wang L, Zhou K
Antioxidants (Basel). 2025; 14(2).
PMID: 40002408
PMC: 11852102.
DOI: 10.3390/antiox14020222.
Oskomic M, Tomic A, Barbaric L, Matic A, Kindl D, Matovina M
Cancers (Basel). 2025; 17(3).
PMID: 39941813
PMC: 11816071.
DOI: 10.3390/cancers17030447.
Zhang Z, Guo J
Antioxidants (Basel). 2025; 14(1).
PMID: 39857372
PMC: 11759168.
DOI: 10.3390/antiox14010038.
Liu D, Zhu Y
Cells. 2024; 13(23).
PMID: 39682718
PMC: 11639856.
DOI: 10.3390/cells13231969.
Zhu F, Li L, Chen Y, Pan Y, Zhang W, Li L
Nat Commun. 2024; 15(1):10536.
PMID: 39627198
PMC: 11615322.
DOI: 10.1038/s41467-024-54919-2.
Antioxidant 1,2,3,4,6-Penta--galloyl-β-D-glucose Alleviating Apoptosis and Promoting Bone Formation Is Associated with Estrogen Receptors.
Hua Y, Wang H, Chen T, Zhou Y, Chen Z, Zhao X
Molecules. 2024; 29(21).
PMID: 39519751
PMC: 11547736.
DOI: 10.3390/molecules29215110.
FGF21 Alleviates Hypoxic-Ischemic White Matter Injury in Neonatal Mice by Mediating Inflammation and Oxidative Stress Through PPAR-γ Signaling Pathway.
Fang M, Lu L, Lou J, Ou J, Yu Q, Tao X
Mol Neurobiol. 2024; 62(4):4743-4768.
PMID: 39485628
DOI: 10.1007/s12035-024-04549-y.
Interplay of Cellular Nrf2/NF-κB Signalling after Plasma Stimulation of Malignant vs. Non-Malignant Dermal Cells.
Manzhula K, Rebl A, Budde-Sagert K, Rebl H
Int J Mol Sci. 2024; 25(20).
PMID: 39456749
PMC: 11507371.
DOI: 10.3390/ijms252010967.
Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.
Qiu M, Ma K, Zhang J, Zhao Z, Wang S, Wang Q
Front Pharmacol. 2024; 15:1395735.
PMID: 39444605
PMC: 11496173.
DOI: 10.3389/fphar.2024.1395735.
Potential of NRF2 Inhibitors-Retinoic Acid, K67, and ML-385-In Overcoming Doxorubicin Resistance in Promyelocytic Leukemia Cells.
Juszczak M, Tokarz P, Wozniak K
Int J Mol Sci. 2024; 25(19).
PMID: 39408587
PMC: 11476837.
DOI: 10.3390/ijms251910257.
The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs.
Zhang M, Wang J, Liu R, Wang Q, Qin S, Chen Y
Heliyon. 2024; 10(18):e37326.
PMID: 39309822
PMC: 11414506.
DOI: 10.1016/j.heliyon.2024.e37326.
Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells.
Fournier L, Kalantari F, Wells J, Lee J, Trigo-Gonzalez G, Moksa M
Cancers (Basel). 2024; 16(17).
PMID: 39272807
PMC: 11394604.
DOI: 10.3390/cancers16172949.
Optimization of a Modular Nanotransporter Design for Targeted Intracellular Delivery of Photosensitizer.
Alieva R, Ulasov A, Khramtsov Y, Slastnikova T, Lupanova T, Gribova M
Pharmaceutics. 2024; 16(8).
PMID: 39204428
PMC: 11360004.
DOI: 10.3390/pharmaceutics16081083.
Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent Genes.
Lorenz L, Zenz T, Oliinyk D, Meier-Rosar F, Jenke R, Aigner A
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204185
PMC: 11357633.
DOI: 10.3390/ph17081080.
Transcriptional Dynamics of NRF2 Overexpression and KEAP1-NRF2 Inhibitors in Human Cell Line and Primary Lung Cells.
Hamblet C, Bjorhall K, Busch S, Gehrmann U, Oberg L, Kubisch-Dohmen R
Antioxidants (Basel). 2024; 13(8).
PMID: 39199170
PMC: 11351141.
DOI: 10.3390/antiox13080924.
Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers.
Ajuwon O, Nsole-Biteghe F, Ndong J, Davids L, Ajiboye B, Brai B
Onco Targets Ther. 2024; 17:605-627.
PMID: 39131905
PMC: 11313505.
DOI: 10.2147/OTT.S457749.
NRF2-dependent regulation of the prostacyclin receptor PTGIR drives CD8 T cell exhaustion.
Dahabieh M, DeCamp L, Oswald B, Kitchen-Goosen S, Fu Z, Vos M
bioRxiv. 2024; .
PMID: 38979360
PMC: 11230227.
DOI: 10.1101/2024.06.23.600279.
Comparative Study of the Potential Cell-Penetrating Peptide ∆M4 on Apoptosis Cell Signaling in A375 and A431 Cancer Cell Lines.
Fandino-Devia E, Brankiewicz A, Santa-Gonzalez G, Guevara-Lora I, Manrique-Moreno M
Pharmaceutics. 2024; 16(6).
PMID: 38931896
PMC: 11207241.
DOI: 10.3390/pharmaceutics16060775.
The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment.
Wang L, Zhang L, Bai X, Qiang R, Zhang N, Hu Q
Neurochem Res. 2024; 49(10):2653-2667.
PMID: 38864944
DOI: 10.1007/s11064-024-04194-w.
Experimental verification about treatment of Bu-Shen-Yi-Jing-Fang in Alzheimer's disease by the analysis of the feasible signaling pathway of network pharmacology.
Hu Y, Hao R, Li D, Lu Y, Yu G
BMC Complement Med Ther. 2024; 24(1):222.
PMID: 38851758
PMC: 11162075.
DOI: 10.1186/s12906-024-04527-w.